Show simple item record

dc.contributor.authorTomari, S
dc.contributor.authorMagin, P
dc.contributor.authorLasserson, D
dc.contributor.authorQuain, D
dc.contributor.authorValderas, JM
dc.contributor.authorDewey, HM
dc.contributor.authorBarber, PA
dc.contributor.authorSpratt, NJ
dc.contributor.authorCadilhac, DA
dc.contributor.authorFeigin, VL
dc.contributor.authorRothwell, PM
dc.contributor.authorZareie, H
dc.contributor.authorGarcia-Esperon, C
dc.contributor.authorDavey, A
dc.contributor.authorNajib, N
dc.contributor.authorSales, M
dc.contributor.authorLevi, CR
dc.date.accessioned2020-06-12T13:44:02Z
dc.date.issued2020-05-15
dc.description.abstractBackground: Transient ischemic attack (TIA) and minor stroke (TIAMS) are risk factors for stroke recurrence. Some TIAMS may be preventable by appropriate primary prevention. We aimed to recruit “possible-TIAMS” patients in the INternational comparison of Systems of care and patient outcomes In minor Stroke and TIA (INSIST) study. Methods: A prospective inception cohort study performed across 16 Hunter–Manning region, Australia, general practices in the catchment of one secondary-care acute neurovascular clinic. Possible-TIAMS patients were recruited from August 2012 to August 2016. We describe the baseline demographics, risk factors and pre-event medications of participating patients. Results: There were 613 participants (mean age; 69 ± 12 years, 335 women), and 604 (99%) were Caucasian. Hypertension was the most common risk factor (69%) followed by hyperlipidemia (52%), diabetes mellitus (17%), atrial fibrillation (AF) (17%), prior TIA (13%) or stroke (10%). Eighty-nine (36%) of the 249 participants taking antiplatelet therapy had no known history of cardiovascular morbidity. Of 102 participants with known AF, 91 (89%) had a CHA2DS2-VASc score ≥ 2 but only 47 (46%) were taking anticoagulation therapy. Among 304 participants taking an antiplatelet or anticoagulant agent, 30 (10%) had stopped taking these in the month prior to the index event. Conclusion: This study provides the first contemporary data on TIAMS or TIAMS-mimics in Australia. Community and health provider education is required to address the under-use of anticoagulation therapy in patients with known AF, possibly inappropriate use of antiplatelet therapy and possibly inappropriate discontinuation of antiplatelet or anticoagulation therapy.en_GB
dc.description.sponsorshipNational Health and Medical Research Councilen_GB
dc.identifier.citationVol. 11, article 383en_GB
dc.identifier.doi10.3389/fneur.2020.00383
dc.identifier.grantnumber1027794en_GB
dc.identifier.urihttp://hdl.handle.net/10871/121403
dc.language.isoenen_GB
dc.publisherAmerican Academy of Neurologyen_GB
dc.rights© 2020 Tomari, Magin, Lasserson, Quain, Valderas, Dewey, Barber, Spratt, Cadilhac, Feigin, Rothwell, Zareie, Garcia-Esperon, Davey, Najib, Sales and Levi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_GB
dc.subjecttransient ischemic attacken_GB
dc.subjectminor strokeen_GB
dc.subjectstroke-mimic syndromeen_GB
dc.subjectatrial fibrillationen_GB
dc.subjectanticoagulation therapyen_GB
dc.titleThe characteristics of patients with possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley regions, Australia (the INSIST Study)en_GB
dc.typeArticleen_GB
dc.date.available2020-06-12T13:44:02Z
dc.identifier.issn0028-3878
dc.descriptionThis is the final version. Available on open access from the American Academy of Neurology via the DOI in this record. en_GB
dc.identifier.eissn1526-632X
dc.identifier.journalFrontiers in Neurologyen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2020-04-15
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-04-15
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-06-12T13:37:53Z
refterms.versionFCDVoR
refterms.dateFOA2020-06-12T13:44:05Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 Tomari, Magin, Lasserson, Quain, Valderas, Dewey, Barber, Spratt, Cadilhac, Feigin, Rothwell, Zareie, Garcia-Esperon, Davey, Najib, Sales and Levi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Except where otherwise noted, this item's licence is described as © 2020 Tomari, Magin, Lasserson, Quain, Valderas, Dewey, Barber, Spratt, Cadilhac, Feigin, Rothwell, Zareie, Garcia-Esperon, Davey, Najib, Sales and Levi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.